Katie Eder, Senior Editor

The FDA today approved the first non-invasive colorectal screening test to indicate the presence of certain abnormal growths that may be colorectal cancer or precursors to colon cancer.

Alasdair James has been named president and chief member officer for Kmart.

Community pharmacists dramatically boost medication adherence among patients with chronic conditions.

In a recent study, patients with diabetes who were referred to a pharmacist-led clinic by their primary care providers saw their mean HbA1C levels fall by 2.4%.

With its expanded approval of Lumizyme (alglucosidase alfa) to treat all Pompe disease patients, regardless of age or time of disease onset, the FDA has eliminated the Risk Evaluation and Mitigation Strategy program that restricted the drug's use to those aged 8 years or older with late-onset disease.

The FDA has approved a new dosage strength of Flexbumin (albumin [human]) to treat hypovolemia and other critical conditions.